Clinical Trial Update: Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A [Phase 2]

View source ↗

Summary

Phase II randomized, placebo-controlled trial in Charcot-Marie-Tooth disease type 1A completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 1a
• Hereditary Neuropathy with Liability to Pressure Palsies

Drugs mentioned

• PXT-3003

Snippet

Sponsor: Pharnext S.C.A. | Conditions: Charcot-Marie-Tooth Disease, Hereditary Neuropathy With Liability to Pressure Palsies | Phase 2 | Status: COMPLETED | Results posted: 2017-02-16